Similar enhanced radiosensitisation of head and neck squamous cell carcinoma cells in response to protons at the SOBP with the alternative PARP inhibitor niraparib has also been observed [73]. The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.